Get notified when CHRN files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsStanding Risk Factors
- Going Concern (unchanged) — The auditor's report contains a going-concern warning, indicating substantial doubt about the company's ability to continue operating.
ChronoScale Holdings prices $6.0M unit offering at $1.00 per unit, netting $5.1M
Filed August 30, 2024 · ~1 min read
Key Changes
-
high
Offering of 3.1M units at $1.00 each and 2.9M pre-funded units at $0.999 each; gross proceeds $5,997,100, net proceeds to company $5.1M.
The Offering verify on EDGAR → -
medium
Net proceeds of $5.1M will be used for general corporate purposes, including EksoHealth growth, R&D, SG&A, and potential acquisitions; no dividends planned.
Use of Proceeds verify on EDGAR → -
high
New investors face immediate dilution of $0.51 per share; net tangible book value rises from $0.37 to $0.49 per share.
Dilution verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SAR 10-Q) is open in full — no account needed.
Partner
Trade CHRN commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 3, 2026 · How we verify